Hepatocyte-Specific Deletion of EGFR in Mice Reduces Hepatic Abcg2 Transport Activity Measured by [11C]erlotinib and Positron Emission Tomography

AMIDE: A Free Software Tool for Multimodality Medical Image Analysis

Andreas M. Loening, Sanjiv S. Gambhir · Molecular Imaging · 2003 · 977 citations · Full text

Computing, Biomedical Informatics, Visualization +16

SEARCH: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Sorafenib Plus Erlotinib in Patients With Advanced Hepatocellular Carcinoma

Andrew X. Zhu, Olivier Rosmorduc, T.R. Jeffry Evans et al. · Journal of Clinical Oncology · 2014 · 577 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Increased Oral Bioavailability of Topotecan in Combination With the Breast Cancer Resistance Protein and P-Glycoprotein Inhibitor GF120918

C.M.F. Kruijtzer, Jos H. Beijnen, Hilde Rosing et al. · Journal of Clinical Oncology · 2002 · 462 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Erlotinib (Tarceva, OSI-774) Antagonizes ATP-Binding Cassette Subfamily B Member 1 and ATP-Binding Cassette Subfamily G Member 2–Mediated Drug Resistance

Zhi Shi, Xing-Xiang Peng, In‐Wha Kim et al. · Cancer Research · 2007 · 329 citations

Medicine, Oncology, Pharmacology +16

The EGF receptor is required for efficient liver regeneration

Anuradha Natarajan, Bettina Wagner, Maria Sibilia · Proceedings of the National Academy of Sciences · 2007 · 315 citations · Full text

Life Sciences, Developmental Biology, Molecular Genetics +17